Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICECAP 1: YP-P10 Ophthalmic Solution for Dry Eye
NCT05467293Phase 2Completed
- Sponsor
- Yuyu Pharma
- Start
- Jun 2022
- Primary completion
- Mar 2023
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of YP-P10 Placebo Ophthalmic Solution in dry eye disease (DED) (3 arms), sponsored by Yuyu Pharma. Primary endpoints: Total Corneal Fluorescein Staining Score at Day 85 and Ocular Discomfort Score at Day 85. Started Jun 2022; status: completed.
02
Drugs
YP-P10 Placebo Ophthalmic Solution
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT05467293.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05467293.